pelvic organ prolapse female urogenital diseases
Conditions
Interventions
This is a prospective, observational, non-randomized, non-masked study designed to validate a treatment algorithm for female apical pelvic organ prolapse. More than 353 symptomatic women with uterine
s Hospital (Centro de Atenção Integral à Saúde da Mulher – CAISM), University of Campinas (Universidade Estadual de Campinas – UNICAMP). According to the clinical indication, participants may undergo
Sponsors
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: women with symptomatic uterine prolapse or vaginal vault prolapse, classified as stages 1, 2, 3, or 4 according to the pelvic organ prolapse classification system; women who voluntarily agree to participate and provide written informed consent
Exclusion criteria
Exclusion criteria: women without apical pelvic organ prolapse; women with cognitive impairment preventing adequate understanding of the questionnaires; women with a history of or current treatment for gynecological malignancy; pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the aim is to validate the flowchart for the treatment of apical genital prolapse in women by evaluating the anatomical success rate post-treatment, defined as stage = 2 prolapse with points C, Ba, and Bp = -1 according to the pelvic organ prolapse quantification system. the assessment will be conducted prior to treatment and at the 12-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| the aim is to evaluate the subjective cure rate based on the patient's perception of symptom improvement at 12 months | — |
Countries
BR
Contacts
Public ContactEdilson de Castro
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Outcome results
None listed